Trial Profile
An Open-label, Multiple-Dose Escalation Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced Thrombocytopenia
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs NIP 022 (Primary)
- Indications Thrombocytopenia
- Focus Adverse reactions
- Sponsors Ono Pharmaceutical
- 16 Dec 2015 New trial record